JeffreySFreemanDO

PubMed

• Management of hypoglycemia in older adults with type 2 diabetes.
  Freeman, J.> ;Postgraduate medicine. 2019 Feb 7
• Hot Topics in Primary Care: Considerations in the Selection of Antihyperglycemic Therapy for Older Patients With Type 2 Diabetes Mellitus: A Focus on Newer Therapies.
  Freeman J> ;J Fam Pract. 2015-12-01
• Initial Combination Therapy for Patients with Type 2 Diabetes Mellitus: Considerations for Metformin Plus Linagliptin
  Jeffrey S. Freeman> ;Drugs in context. 2013 Aug 21
• 7 citations
  Review of Insulin-Dependent and Insulin-Independent Agents for Treating Patients with Type 2 Diabetes Mellitus and Potential Role for Sodium-Glucose Co-Transporter 2 I...
  Jeffrey Freeman, DO> ;Taylor & Francis Online. 2013 Jun 12
• 1 citation
  What have we learned about the treatment of type 2 diabetes? The evolving paradigms.
  Freeman, J. S., Horton, E. S.> ;American journal of therapeutics. 2012 Nov 17
• 5 citations
  Potential drug interactions associated with treatments for type 2 diabetes and its comorbidities: a clinical pharmacology review.
  Freeman, J. S., Gross, B. N.> ;Expert review of clinical pharmacology. 2011 Dec 7
• Type 2 diabetes mellitus: practical approaches for primary care physicians.
  James R. Gavin, Jeffrey S. Freeman, Jay H. Shubrook, Frank Lavernia> ;The Journal of the American Osteopathic Association. 2011 May 1
• 5 citations
  A physiologic and pharmacological basis for implementation of incretin hormones in the treatment of type 2 diabetes mellitus.
  Freeman, J. S.> ;Mayo Clinic proceedings. 2010 Nov 26
• Illustrative case and discussion: a 58-year-old man with diabetes.
  Freeman, J.S.> ;J Am Osteopath Assoc. 2010 Jul
• Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges.
  Gavin, J.R., Stolar, M.W., Freeman, J.S., Spellman, C.W.> ;J Am Osteopath Assoc. 2010 May
• 19 citations
  Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
  Freeman, J. S.> ;Cleveland Clinic journal of medicine. 2010 Jan 9
• Why and when to implement incretin therapy.
  Freeman, J.S., Unger, J.> ;J Fam Pract. 2008-09-01
• Application of incretin mimetics and dipeptidyl peptidase IV inhibitors in managing type 2 diabetes mellitus.
  Boyle, P.J., Freeman, J.S.> ;J Am Osteopath Assoc. 2007 May
• Reducing the "domino effect" of the metabolic syndrome.
  Freeman, J.S.> ;J Am Osteopath Assoc. 2007 Apr
• Blood glucose in the hospital. Doctors are starting to see that tight glucose control saves lives.
  Jeffrey S. Freeman> ;Diabetes forecast. 2005 Sep 1
• Diabetes-related clinical issues represented by the "Faces of Diabetes".
  Freeman, J. S.> ;The Journal of the American Osteopathic Association. 2003 Sep 10
• Barriers to communication about diabetes mellitus. Patients' and physicians' different view of the disease.
  Freeman J, Loewe R> ;J Fam Pract. 2000-06-01
• Empty sella syndrome associated with partial hypopituitarism (visualized on MRI scan).
  Serpico PC, Freeman JS, Marks B> ;J Am Osteopath Assoc. 1992-09-01
• Graves' disease in association with pernicious anemia: report of a case and review of the literature.
  Fierro VS, Freeman JS, Maranzini P> ;J Am Osteopath Assoc. 1985-11-01
• Colchicine overdosage: report of a case.
  Freeman JS, Panebianco PS> ;J Am Osteopath Assoc. 1982-12-01
• Substernal thyroid and thyrotoxicosis: report of case.
  Freeman JS, Haenel LC> ;J Am Osteopath Assoc. 1982-07-01
• Join now to see all